cell-based therapies

systematic review meta-analysis network meta-analysis

Select acute myocardial infarctioncoronary artery diseaseheart failureperipheral vascular diseases All type of patientuncoded clinical condition ***untractable angina       bone marrow derived stem cellCardiac stem cellsgene therapygene transfergrowth factorixmyelocel-Tmyoblastsstem cells fibroblast growth factorgene therapy vs control or placebovs placebo or control      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results	All cause death (21)angiographic restenosis (10)Deaths or MI (9)Arrhythmia (7)MACE (7)target-vessel revascularization (7)reinfarction (7)acute heart failure (3)NYHA deterioration (2) Options Numeric bar chart forest plot medians
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	All cause death	angiographic restenosis
coronary artery disease
fibroblast growth factor
FIRST (Simons), 2002	fibroblast growth factor	placebo			Low risk of bias	-
AGENT-1 (Grines), 2002	fibroblast growth factor gene	placebo				-
AGENT-2 (Grines), 2003	fibroblast growth factor gene	placebo				-
AGENT-3    NCT	fibroblast growth factor gene	placebo				-
AGENT-4    NCT	fibroblast growth factor gene	placebo				-
AWARE    NCT	fibroblast growth factor gene	placebo			Low risk of bias	-
AGENT 3 and 4 pooled	fibroblast growth factor gene	placebo				-
gene therapy
EUROINJECT-ONE (Gyöngyösi), 2005	gene therapy	placebo			Low risk of bias	-